ASA Launches International Research Center – International Cannabis and Cannabinoid Institute (ICCI) 2

ASA Launches International Research Center – International Cannabis and Cannabinoid Institute (ICCI)



Americans for Safe Access (ASA), KOPAC and Dioscorides Global Holdings (DGH) were joined by the Minister of Health for the Czech Republic, Svatopluk Němeček to announce the establishment of a new research center, the International Cannabis and Cannabinoid Institute (ICCI) – intended to foster evidence-based exploration with a modern scientific approach to refine the therapeutic applicability of cannabis-based medicines in the Czech Republic. ICCI will identify, coordinate and support global research priorities for the advancement of cannabis and cannabinoid treatments through a multidisciplinary evidence based approach that incorporates innovative tools and approaches.

Decades since cannabis was first included in the 1961 UN Convention on Narcotic Drugs Schedule IV list of restricted drugs, new scientific and medical research has revealed many health and therapeutic benefits of cannabis. In the arena of cannabis research, scientists have observed both the therapeutic effects and safety profile in diverse patient groups who have already received cannabis as a part of clinical trials. These findings have been challenging to investigate due to an array of circumstances such as the international criminalization of the cannabis plant, scarcity of available research institutions, and lack of funding.

Despite these hurdles, millions of people are finding relief using cannabis treatments for an array of medical conditions and symptoms. Currently, two-thirds of the US population live in states with medical cannabis laws, and over 2 million Americans currently use medical cannabis as a treatment option. Canada, Israel, Netherlands, Czech Republic, Croatia, Mexico, Uruguay, Romania, Germany, Jamaica, Australia, Colombia, and Switzerland all have national medical cannabis programs, while dozens of other countries are in the process of reviewing legislation.

As an international collaborative project of nonprofit, for-profit, and government institutions, ICCI has developed strategic project partnership alliances with participation from Universities, Hi-Tech Companies, and Institutions from around the globe and will become an international research and educational hub designed to meet the needs of patients globally. ICCI is connecting a cross-disciplinary approach that captures the current knowledge base across the fields of biomedical research, social science, life sciences, and policy research with the sole purpose of identifying and resolving barriers to advancements. The results are to be shared across academia, research institutes, private endowments, governments, medical professional, patient advocacy organizations, health service providers, and product manufacturers.

source

Leave a Comment

Your email address will not be published. Required fields are marked *

×

Hello!

Click one of our representatives below to chat on WhatsApp or send us an email to [email protected]

 

× Order Via Whatsapp?